Free content from across the British Medical Journal (BMJ) to celebrate World Lupus Day
We've selected a number of our products to showcase in celebration of World Lupus Day. Read on for free articles from our world-renowned journals and free access to a lupus module from BMJ Learning, as well as an exclusive offer from Lupus Science & Medicine, the first Open Access lupus journal. Please share this with friends and colleagues to help spread awareness of lupus.
Lupus Science & Medicine: the first lupus-specific Open Access journal in the world
Lupus Science & Medicine is a global, peer reviewed, Open Access journal providing a central point for publication of basic, clinical, translational and epidemiological studies of all aspects of lupus and related diseases. It is an official journal of the Lupus Foundation of America (LFA), which is dedicated to advancing the science and medicine of lupus while offering support to patients and their caregivers.
Clinical phenotype associations with various types of anti-dsDNA antibodies in patients with recent onset of rheumatic symptoms. Results from a multicentre observational study Dr Michele Compagno, et al.
Which outcome measures in SLE clinical trials best reflect medical judgment? Dr Aikaterini Thanou, Eliza Chakravarty, Judith A James and Joan T Merrill
Vitamin D deficiency is common and associated with increased C-reactive protein in children and young adults with lupus: an Atherosclerosis Prevention in Pediatric Lupus Erythematous substudy Dr Angela Byun Robinson, et al.
Reduced response to Epstein-Barr virus antigens by T-cells in systemic lupus erythematous patients Professor Gunnar Houen, et al.
Value of repeat biopsy in lupus nephritis flares Professor Enrique R Soriano, et al.
Pregnancy outcomes among African-American patients with systemic lupus erythmatosus compared with controls Dr Diane L Kamen, Lee Wheless, Anna K Meyer and Gary S Gilkeson
Free and Open Access content from Annals of the Rheumatic Diseases:
Annals of the Rheumatic Diseases is an international, peer-reviewed journal committed to promoting the highest standards of scientific exchange and education. With an Impact Factor of 9.111, it is the number 1 original research journal in the field of Rheumatology.
When to order an antinuclear antibody test Allan Binder and Spencer Ellis
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force Dr Ronald van Vollenhoven, et al.
Cigarette smoking, antiphopholipid antibodies and vascular events in Systemic Lupus Erythematous Dr Johanna T Gustafsson, et al.
Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment Dr Chary López-Pedrera, et al.
Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials Dr Vibeke Strand, et al.